Rick Schneider is a family man — a husband and doting father to three girls. He’s also an outdoorsman who loves to bike, hike ...

We spoke with Mark Boothby, Professor of Immunology at Vanderbilt University, about his experience publishing with eLife.

He didn't feel sick at all.Nathan Calhoun was young, he was fit, he was in a brand-new relationship, he had just started a ...

The experimental group had significantly higher levels of white blood cells, neutrophils, C-reactive protein (CRP), serum amyloid A (SAA), neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein ...

I have always had a bias towards the Appeal to Nature Fallacy:An Appeal to Nature Fallacy happens when someone argues that ...

US Bancorp DE reduced its stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 36.4% during the ...

Switching to islatravir and doravirine was just as effective as bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC ...

Scientists have made an important discovery about the relationship between hematopoietic stem cells (HSCs) and immune response evasion. Their findings show how certain HSCs have regulatory functions ...

Discover Iovance's Q4'24 revenue growth, Proleukin's impact on Amtagvi's future, and how it faces competition like Obsidian's ...

Tumor inflitrating lymphocyte therapies are a promising type of cellular immunotherapy used to treat a broad range of solid malignant tumors.

The measles virus attacks long-lived immune cells, reducing antibody-mediated protection from other infectious diseases and ...